Literature DB >> 2147362

Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy.

I Bartels1, M Thiele, M H Bogart.   

Abstract

In a retrospective study, maternal serum levels of chorionic gonadotropin (hCG) and pregnancy specific beta 1-glycoprotein (SP1) from 63 pregnancies with aneuploid fetuses were compared to the levels observed in pregnancies with a chromosomally normal fetus. Thirty-eight percent of the abnormal pregnancies had elevated levels (greater than 2.0 multiples of the normal median [MoM]) of hCG and 14% had depressed levels (less than 0.25 MoM). With a false-positive rate of 5%, 44% of the 42 fetuses with trisomy 21 would have been detected by elevated hCG levels. With the same false-positive rate, only 21% had elevated SP1 levels. hCG was significantly depressed in 12 pregnancies affected by fetal trisomy 18.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2147362     DOI: 10.1002/ajmg.1320370220

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  2 in total

Review 1.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

2.  Risk of fetal Down's syndrome based on maternal age and varying combinations of maternal serum markers.

Authors:  I Bartels; B Bockel; J Caesar; M Krawczak; M Thiele; R Rauskolb
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.